Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1084 Results

Intervention Indication Therapeutic Area Year Actions
Sintilimab in combination with pemetrexed and platinum chemotherapy for advanced or metastatic non-small cell lung cancer Carboplatin (Paraplatin) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) , Sintilimab (IBI 308; IBI 380; Tyvyt) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Sirolimus-eluting collagen implant for preventing vascular access failure in end stage renal disease patients undergoing haemodialysis Sirolimus-eluting collagen implant Renal disease Cardiovascular System , Immunology 2023 View  |  Download
Sodium phenylbutyrate-ursodoxicoltaurine for treating amyotrophic lateral sclerosis Sodium phenylbutyrate-ursodoxicoltaurine Amyotrophic lateral sclerosis Neurology 2022 View  |  Download
Sodium thiosulfate for acute calciphylaxis-associated pain in chronic haemodialysis patients Sodium Thiosulfate (Pedmark; BYON5667) Calciphylaxis Cardiovascular System 2018 View  |  Download
Sotagliflozin for type 2 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2019 View  |  Download
Sotagliflozin tablets as an adjuct therapy to insulin for Type 1 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Sotatercept for treating pulmonary arterial hypertension Sotatercep (ACE-011) Pulmonary arterial hypertension (PAH) Cardiovascular System , Respiratory System 2022 View  |  Download
Sparsentan for treating Focal Segmental Glomerulosclerosis Sparsentan (RE-021; PS433540) Focal segmental glomerulosclerosis (FSGS) Nephrology 2021 View  |  Download
Sparsentan for treating primary IgA nephropathy Sparsentan (RE-021; PS433540) IgA nephropathy Immunology , Nephrology 2023 View  |  Download
Spartalizumab in addition to dabrafenib and trametinib for unresectable or metastatic BRAF V600 mutant melanoma – first‐line Dabrafenib (Tafinlar; GSK2118436; dabrafenib mesilate) , Spartalizumab (PDR001) , Trametinib (Mekinist; TMT212; GSK-1120212B; GSK1120212; JTP-74057; trametinib dimethyl sulfoxide) Melanoma Skin Cancer 2019 View  |  Download
1 2 89 90 91 92 93 108 109
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications